Jianwu Fang

Jianwu Fang has 16 years of experience, starting in 2004 as a Research Scientist at Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Jianwu then joined Novartis Institutes for BioMedical Research (NIBR) in 2007 as a Scientist II, where they worked until March 2020. In April 2020, they became the Head of In Vivo Pharmacology at Insilico Medicine.

Jianwu Fang completed their Bachelor of Science degree in Biochemistry at Wuhan University from 1997 to 2001. Jianwu then pursued a Master of Science in Biochemistry, Biophysics, and Cell Biology from Huazhong University of Science and Technology, where they studied from 2001 to 2004. Continuing their academic journey, Jianwu Fang completed their Ph.D. in the same university's Biochemistry, Biophysics, and Cell Biology program, spanning the years 2010 to 2018.